Esther H Chang Selected Research

K(K(H)KKK)5-K(H)KKC

3/2004

Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Esther H Chang Research Topics

Disease

28	Neoplasms (Cancer) 11/2019 - 03/2002
6	Glioblastoma (Glioblastoma Multiforme) 11/2019 - 06/2014
6	Neoplasm Metastasis (Metastasis) 01/2018 - 03/2002
4	Breast Neoplasms (Breast Cancer) 01/2018 - 03/2002
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019 - 02/2002
2	Neuroinflammatory Diseases 01/2018 - 03/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2007 - 01/2006
2	Prostatic Neoplasms (Prostate Cancer) 03/2004 - 02/2002
1	COVID-19 01/2022
1	Infections 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Endotoxemia 01/2018
1	Mouth Neoplasms (Oral Cancer) 01/2018
1	Adenocarcinoma of Lung 01/2018
1	Bites and Stings (Sting) 01/2018
1	Lung Neoplasms (Lung Cancer) 05/2009
1	Carcinoma (Carcinomatosis) 04/2008
1	Melanoma (Melanoma, Malignant) 03/2008

Drug/Important Bio-Agent (IBA)

11	Liposomes (Liposome)IBA 01/2019 - 02/2002
7	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 02/2002
6	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2006
5	Antisense OligonucleotidesIBA 04/2007 - 08/2002
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2002
4	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 06/2014
4	Transferrin (beta 2 Transferrin)IBA 04/2008 - 02/2002
4	Immunoglobulin FragmentsIBA 04/2008 - 01/2006
4	Transferrin Receptors (Transferrin Receptor)IBA 03/2008 - 03/2002
3	Messenger RNA (mRNA)IBA 01/2019 - 12/2003
3	Docetaxel (Taxotere)FDA Link 09/2016 - 08/2002
3	LigandsIBA 10/2008 - 08/2002
3	Folic Acid (Vitamin M)FDA LinkGeneric 12/2004 - 08/2002
2	Gadolinium DTPA (Magnevist)FDA Link 05/2009 - 01/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2008 - 12/2004
2	Monoclonal AntibodiesIBA 12/2003 - 03/2002
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	1,2-oleoylphosphatidylcholine (DOPC)IBA 01/2019
1	Long Noncoding RNAIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	Complementary DNA (cDNA)IBA 01/2018
1	Nanoparticle Drug Delivery SystemIBA 12/2015
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 06/2014
1	PolymersIBA 03/2014
1	Contrast MediaIBA 05/2009
1	ferric oxide (iron oxide)IBA 12/2008
1	Gemcitabine FDA Link 04/2008
1	Mitoxantrone (Novantrone)FDA LinkGeneric 03/2008
1	QuinazolinonesIBA 03/2008
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2006
1	Antisense DNAIBA 01/2006
1	Therapeutic UsesIBA 01/2006
1	RNA (Ribonucleic Acid)IBA 01/2006
1	OligonucleotidesIBA 01/2006
1	Peptides (Polypeptides)IBA 03/2004
1	K(K(H)KKK)5-K(H)KKCIBA 03/2004
1	Fluorescein-5-isothiocyanate (FITC)IBA 12/2003
1	RhodaminesIBA 12/2003
1	Initiator Codon (Start Codon)IBA 12/2003
1	Immunotoxins (Immunotoxin)IBA 12/2003
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2003
1	Taxoids (Taxanes)IBA 08/2002
1	1,2-dielaidoylphosphatidylethanolamine (Lipofectin)IBA 08/2002
1	Indicators and Reagents (Reagents)IBA 08/2002
1	Immunoglobulin Variable RegionIBA 03/2002
1	LipidsIBA 03/2002
1	Pharmaceutical PreparationsIBA 03/2002

Therapy/Procedure

18	Therapeutics 01/2022 - 02/2002
5	Drug Therapy (Chemotherapy) 12/2015 - 08/2002
2	Immunotherapy 11/2019 - 01/2018
1	Injections 01/2019
1	Aftercare (After-Treatment) 08/2002
1	Intravenous Infusions 08/2002
1	Radiotherapy 02/2002